Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates acrolein-induced airway mucus hypersecretion in rats

This publication has 48 references indexed in Scilit:

• Effect of sildenafil on acrolein-induced airway inflammation and mucus production in rats
  European Respiratory Journal, 2009
• Peroxisome proliferator-activated receptor-γ in cystic fibrosis lung epithelium
  American Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
• PPAR-γ agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis
  American Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
• Peroxisome proliferator-activated receptor-γ inhibits cigarette smoke solution-induced mucin production in human airway epithelial (NCI-H292) cells
  American Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
• Treatment of airway mucus hypersecretion
  Annals of Medicine, 2006
• Peroxisome Proliferator-activated Receptor-γ as a Regulator of Lung Inflammation and Repair
  Proceedings of the American Thoracic Society, 2005
• Effect of rosiglitazone and 15-deoxy-Δ^12,14-prostaglandin J₂on bleomycin-induced lung injury
  European Respiratory Journal, 2005
• Neutrophil elastase induces mucus cell metaplasia in mouse lung
  American Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^−ΔΔC_T Method
  Methods, 2001
• Lung mucus: a clinician's view
  European Respiratory Journal, 1997